Medrogestone
| Code | Size | Price |
|---|
| TAR-T33271-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Medrogestone is progesterone that is already used in hormone replacement therapy to treat menopausal symptoms and in the treatment of gynaecological conditions.
CAS:
977-79-7
Formula:
C23H32O2
Molecular Weight:
340.507
Purity:
0.98
SMILES:
[H][C@@]12CC[C@](C)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C
References
Pasqualini JR. Progestins in the menopause in healthy women and breast cancer patients. Maturitas. 2009 Apr 20;62(4):343-8. doi: 10.1016/j.maturitas.2008.12.008. Review. PubMed PMID: 19179024.
Pasqualini JR. Estrogen sulfotransferases in breast and endometrial cancers. Ann N Y Acad Sci. 2009 Feb;1155:88-98. doi: 10.1111/j.1749-6632.2009.04113.x. Review. PubMed PMID: 19250196.
Pasqualini JR. Breast cancer and steroid metabolizing enzymes: the role of progestogens. Maturitas. 2009 Dec;65 Suppl 1:S17-21. doi: 10.1016/j.maturitas.2009.11.006. Epub 2009 Dec 3. Review. PubMed PMID: 19962254.
Schindler AE. Dydrogesterone and other progestins in benign breast disease: an overview. Arch Gynecol Obstet. 2011 Feb;283(2):369-71. doi: 10.1007/s00404-010-1456-7. Epub 2010 Apr 11. Review. PubMed PMID: 20383772.